Related Experiment Video
Updated: Apr 11, 2026

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
Published on: February 17, 2016
MicroRNA: Key regulators of oligodendrocyte development and pathobiology
John-Mark K Fitzpatrick1, Rebecca C Anderson1, Kieran W McDermott1
1Graduate Entry Medical School, University of Limerick, Ireland.
Abstract:
MicroRNAs (miRNAs or miRs) are a group of small non-coding RNAs that function through binding to messenger RNA (mRNA) targets and downregulating gene expression. miRNAs have been shown to regulate many cellular functions including proliferation, differentiation, development and apoptosis. Recently, evidence has grown which shows the involvement of miRs in oligodendrocyte (OL) specification and development. In particular, miRs-138, -219, -338, and -9 have been classified as key regulators of OL development, acting at various points in the OL lineage and influencing precursor cell transit into mature myelinating OLs. Many studies have emerged which link miRNAs with OL and myelin pathology in various central nervous system (CNS) diseases including multiple sclerosis (MS), ischemic stroke, spinal cord injury, and adult-onset autosomal dominant leukodystrophy (ADLD).
Insights
MicroRNAs regulate gene expression and cell functions. Specific microRNAs are key to oligodendrocyte development and are implicated in central nervous system diseases like multiple sclerosis.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression by targeting messenger RNA (mRNA).
- miRNAs are crucial for cellular functions like proliferation, differentiation, development, and apoptosis.
- Emerging evidence highlights miRNA involvement in oligodendrocyte (OL) specification and development.
Purpose of the Study:
- To review the role of specific microRNAs in oligodendrocyte development.
- To explore the link between miRNAs and myelin pathology in central nervous system (CNS) diseases.
Main Methods:
- Literature review of studies on miRNAs, oligodendrocyte development, and CNS diseases.
- Analysis of specific miRNAs (miR-138, -219, -338, -9) identified as key regulators.
Main Results:
- Specific miRNAs, including miR-138, -219, -338, and -9, are critical regulators of oligodendrocyte lineage progression.
- These miRNAs influence the transition from precursor cells to mature, myelinating oligodendrocytes.
- miRNAs are implicated in the pathology of CNS disorders such as multiple sclerosis, ischemic stroke, spinal cord injury, and ADLD.
Conclusions:
- Specific miRNAs play vital roles in normal oligodendrocyte development.
- Dysregulation of these miRNAs is associated with various central nervous system pathologies, suggesting therapeutic potential.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Master Transcription Regulators

